1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with gemcitabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B; Miao, Z; Wang, C; Wang, Y; Wu, Y; Yao, J; Zhang, Y; Zhu, Y | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
2 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and gemcitabine
| Article | Year |
|---|---|
Discovery of natural product ellagic acid as a potent CD73 and CD39 dual inhibitor.
Topics: 5'-Nucleotidase; Antineoplastic Agents; Apyrase; Biological Products; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Ellagic Acid; Enzyme Inhibitors; GPI-Linked Proteins; Humans; Molecular Structure; Structure-Activity Relationship | 2021 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |